BUKWANG PHARMACEUTICAL IND CO.,LTD (003000.KS)
003000.KS on Korea Stock Exchange
13,700.00KRW
10 Feb 2010
13,700.00KRW
10 Feb 2010
Price Change (% chg)
₩100.00 (+0.74%)
₩100.00 (+0.74%)
Prev Close
₩13,600.00
₩13,600.00
Open
₩13,700.00
₩13,700.00
Day's High
₩13,700.00
₩13,700.00
Day's Low
₩13,550.00
₩13,550.00
Volume
92,620
92,620
Avg. Vol
141,749
141,749
52-wk High
₩23,150.00
₩23,150.00
52-wk Low
₩13,500.00
₩13,500.00
About
Bukwang Pharmaceutical Co., Ltd. is a Korea-based manufacturer and distributor of pharmaceutical products. The Company offers a range of products, including ethical drugs, such as diabetes medicines, liver disorder remedies, gastrointestinal system disorder remedies, respiratory disease remedies, circulatory system disorder... (more)
Overall
| Beta: | 0.82 |
| Market Cap (Mil.): | ₩361,998.09 |
| Shares Outstanding (Mil.): | 26.62 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| 003000.KS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 10.54 | 6.43 | 3.76 |
| EPS (TTM): | 70.42 | -- | -- |
| ROI: | 22.12 | 5.95 | 2.30 |
| ROE: | 22.63 | 8.98 | 2.82 |
Korea Hot Stocks - Bukwang Pharm, Samsung Techwin, shipbuilders
SEOUL, April 21 (Reuters) - As of 0230 GMT on Tuesday, the
UPDATE 2-Pharmasset stops hepatitis B trial, shares drop
BANGALORE, April 20 (Reuters) - Pharmasset Inc said it stopped a late-stage study of its experimental treatment for chronic hepatitis B due to several serious adverse events in patients receiving the drug, sending its shares down 17 percent.





Earnings vs
Estimates